Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intercure Ltd. - ordinary shares
(NQ:
INCR
)
1.700
-0.090 (-5.03%)
Streaming Delayed Price
Updated: 12:59 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intercure Ltd. - ordinary shares
< Previous
1
2
3
Next >
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
September 14, 2024
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.
Via
Benzinga
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
August 30, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
August 28, 2024
From
InterCure
Via
Business Wire
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon
July 18, 2024
Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
5 Value Stocks In The Healthcare Sector
May 08, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 17, 2023
Via
Benzinga
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
May 24, 2024
The potential rescheduling of cannabis in the U.S.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
May 22, 2024
From
InterCure Ltd.
Via
Business Wire
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
May 02, 2024
"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.
Via
Benzinga
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
May 01, 2024
From
InterCure Ltd.
Via
Business Wire
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict
April 01, 2024
Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
April 01, 2024
From
InterCure Ltd.
Via
Business Wire
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
March 22, 2024
From
InterCure Ltd.
Via
Business Wire
Canndoc Reports Record Revenue Amid Cannabis Market Turmoil
September 01, 2023
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 18, 2023
August 18, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Medical Cannabis Company Better Is Suing InterCure For $35M
June 15, 2023
Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million.
Via
Benzinga
InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details
May 16, 2023
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million)...
Via
Benzinga
Marijuana Stock Movers For August 9, 2023
August 09, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Why Are Cannabis Stocks Trading Higher Today?
April 27, 2023
Cannabis stocks shot up in Thursday's pre-market and are holding.
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries
April 20, 2023
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership.
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Nasdaq Down 80 Points; VirTra Shares Spike Higher
April 03, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P...
Via
Benzinga
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 03, 2023
Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.
Via
Benzinga
Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet
April 03, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The...
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.